Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria
about
Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experienceRepeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trialClinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient dataNew developments in anti-malarial target candidate and product profilesA head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trialEfficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferTolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, LiberiaDelayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataComparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa.Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study.Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy.An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquineEfficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan childrenLimited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in ChinaFixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance.Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season.Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugsLongitudinal survey of malaria morbidity over 10 years in Saharevo (Madagascar): further lessons for strengthening malaria control.The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel.Improving malaria control in West Africa: interruption of transmission as a paradigm shift.Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in IndiaEffectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impactClinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa.Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa.In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old man with relapsing malaria in Antananarivo, Madagascar.Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysisImpact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trialSafety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.
P2860
Q21034090-E326AB35-BDB4-447D-88A0-CFFE13ACBAE9Q24597403-3387A78E-91C8-405C-9D35-2D7945071543Q26783902-1BE2EE09-85C2-478E-A3C0-76B3D346DE47Q28468598-F0613B15-1527-4339-9F54-DF06B7D84F43Q28477853-DFD5BAF4-7139-4A6B-B2C1-AC25D816C6CBQ28691396-E5550604-1A26-4A6F-8EF2-2781B1FCC7EBQ28691509-732080FA-65D4-4AB2-912D-2DA60FF46C6BQ30850979-EEAF7FFC-4C98-402D-AC00-04969B67B9E1Q30936416-82431983-6222-41C7-B7B1-0A4DAF73FD53Q33399342-5890CA9E-D3CC-4130-9416-D1D614D522F4Q33686633-82FDBC80-4A0C-4301-9E7F-3BBF3CA00A06Q33876535-A80080CF-BD9B-437C-9A94-2C8EBA6BB952Q34506787-A63C8132-64F6-4D62-B090-B3B0907B96D6Q34600201-7108F535-D6B7-46AE-A22E-15379B0D62AEQ34891749-1C93E83B-0902-4B8A-B955-00EF96036A31Q34922481-FD2F018F-BE9B-4B38-9D73-AEF484495E44Q34996451-54D6DEB1-8686-41EA-8173-7A74E234BC25Q35004430-292E5441-129A-45D5-9FE0-E28C3C712588Q35071899-FF370EEB-185E-4011-AD57-02EF9440EE34Q35101288-FB79A9A9-8B2C-477E-8AF1-FAF14BAFF8B1Q35245962-F4897C50-59F4-44A0-9EC8-EF2E037381BDQ35533577-89D5D815-AC3D-4A80-80B5-C3B6C35CF5C9Q35575322-A58D48E8-7EBE-402B-9AA3-535208ECEAD5Q35761615-C334433C-75CD-4F84-A4F8-9A35CD10E7D6Q35803321-4B983374-2BDA-43F0-9D92-6C8F952B37E0Q35955433-2470BEB7-2F85-443C-9D24-4A6D0430D088Q35986306-F0C5C224-AD28-4CBA-ADC7-9E418902D3FBQ36080127-983BA422-9E9A-4D37-890C-3F1B53480DAEQ36309115-7628C9EB-AFE9-478C-BAAD-54423BB4AF9BQ36316217-19BBAEB3-0220-4479-AE89-6D36C5BCD743Q36413462-AEB4BACC-249F-402E-9A56-59390C4A2E31Q36644511-583AFD4D-FB1A-4148-A14A-EF42DFDE073FQ36711959-5583CA2A-ABE4-427E-B2A7-E0C1BC197D99Q36812874-D400B2BD-EE70-4082-B088-143F6439DD43Q36884930-73B47779-EBAC-4C41-ABDD-92A961358D7DQ36901081-42FA71FA-AA0A-443E-BB64-D313AB2474C1Q37350167-8F530A43-8BCD-4D48-A4B8-D1CBC0338D6DQ37361298-DEF85150-0144-4879-9377-ABE497C71C27Q37555147-CCD04901-9FD7-46B8-8D2C-E4191811C4C4Q37560437-9BBC721F-D0EE-4C79-9817-1C006E4C7CBF
P2860
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@ast
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@en
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@en-gb
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@nl
type
label
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@ast
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@en
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@en-gb
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@nl
altLabel
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@en
prefLabel
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@ast
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@en
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@en-gb
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Randomized, multicentre assess ...... Plasmodium falciparum malaria
@en
P2093
Albert Same-Ekobo
Aminata Traore
Babacar Faye
Doris Forlemu
Ibrahima Ndiaye
Laurence Randrianasolo
Niawanlou Dara
Oumar Gaye
Philippe Brasseur
Valérie Lameyre
P2860
P2888
P3181
P356
10.1186/1475-2875-8-125
P407
P50
P577
2009-01-01T00:00:00Z
P5875
P6179
1013650722